{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:28:13Z","timestamp":1780770493747,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005999","name":"Bangladesh Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biopha.2019.109207","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T18:03:03Z","timestamp":1562954583000},"page":"109207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A nutraceutical composition containing diosmin and hesperidin has osteogenic and anti-resorptive effects and expands the anabolic window of teriparatide"],"prefix":"10.1016","volume":"118","author":[{"given":"Sharmistha","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashis","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyazuddin","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamsundar","family":"Pal China","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konica","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabyasachi","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaur R.","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibedya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.40","article-title":"Bone modeling and remodeling","volume":"19","author":"Seeman","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1095\/biolreprod.108.068536","article-title":"Menopause in nonhuman primates?","volume":"79","author":"Walker","year":"2008","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.biopha.2019.109207_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fendo.2018.00505","article-title":"Advances and unmet needs in the therapeutics of bone fragility","volume":"9","author":"Ramchand","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.biopha.2019.109207_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/156652410791065372","article-title":"Anabolics in osteoporosis: the emerging therapeutic tool","volume":"10","author":"Trivedi","year":"2010","journal-title":"Curr. Mol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2019.109207_bib0025","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"38","key":"10.1016\/j.biopha.2019.109207_bib0030","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.1097\/MD.0000000000001156","article-title":"The efficacy of parathyroid hormone analogues in combination with bisphosphonates for the treatment of osteoporosis: a meta-analysis of randomized controlled trials","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"9886","key":"10.1016\/j.biopha.2019.109207_bib0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2019.109207_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bone.2014.04.033","article-title":"Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats","volume":"67","author":"Amugongo","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2019.109207_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2018.06.014","article-title":"Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis","volume":"168","author":"Rovinski","year":"2018","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109207_bib0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.biopha.2019.109207_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071381","article-title":"Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?","volume":"18","author":"Lecomte","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7-8","key":"10.1016\/j.biopha.2019.109207_bib0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.nut.2007.04.009","article-title":"Orange pulp improves antioxidant status and suppresses lipid peroxidation in orchidectomized male rats","volume":"23","author":"Deyhim","year":"2007","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1152\/japplphysiol.00441.2007","article-title":"Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats","volume":"104","author":"Horcajada","year":"2008","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"10.1016\/j.biopha.2019.109207_bib0070","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/jn\/133.6.1892","article-title":"Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice","volume":"133","author":"Chiba","year":"2003","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.biopha.2019.109207_bib0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1359\/jbmr.080219","article-title":"Diosmetin induces human osteoblastic differentiation through the protein kinase C\/p38 and extracellular signal-regulated kinase 1\/2 pathway","volume":"23","author":"Hsu","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109207_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/000331979704800113","article-title":"Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients","volume":"48","author":"Guilhou","year":"1997","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.biopha.2019.109207_bib0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1476-5381.2011.01637.x","article-title":"A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts","volume":"165","author":"Swarnkar","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2019.109207_bib0090","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/00033197050560i104","article-title":"Chronic venous insufficiency and the therapeutic effects of Daflon 500 mg","volume":"56","author":"Bergan","year":"2005","journal-title":"Angiology"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2019.109207_bib0095","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1177\/0003319703054001S05","article-title":"From symptoms to leg edema: efficacy of Daflon 500 mg","volume":"54","author":"Nicolaides","year":"2003","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.biopha.2019.109207_bib0100","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1002\/jcp.27887","article-title":"Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice","volume":"234","author":"Shao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2019.109207_bib0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.02.002","article-title":"Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats","volume":"295","author":"Pal","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109207_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2017.08.005","article-title":"Globular adiponectin reverses osteo-sarcopenia and altered body composition in ovariectomized rats","volume":"105","author":"China","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2019.109207_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2019.03.024","article-title":"The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts","volume":"164","author":"Pal","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109207_bib0120","article-title":"Greater Skeletal Gains in Ovary Intact Rats at Maturity Are Achieved by Supplementing a Standardized Extract of Butea monosperma Stem Bark that Confers Better Bone Conserving Effect following Ovariectomy and Concurrent Treatment Withdrawal","volume":"2013","author":"Srivastava","year":"2013","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2019.109207_bib0125","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jbmr.434","article-title":"A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action","volume":"26","author":"Sharan","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2019.109207_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biomaterials.2015.03.046","article-title":"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties","volume":"56","author":"Tripathi","year":"2015","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2019.109207_bib0135","doi-asserted-by":"crossref","first-page":"L1012","DOI":"10.1152\/ajplung.90601.2008","article-title":"Tristetraprolin regulates IL-8 mRNA stability in cystic fibrosis lung epithelial cells","volume":"296","author":"Balakathiresan","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109207_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15050878","article-title":"Exercise early and often: effects of physical activity and exercise on women\u2019s bone health","volume":"15","author":"Troy","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.11005\/jbm.2018.25.3.133","article-title":"Treatment of osteoporosis: unmet needs and emerging solutions","volume":"25","author":"Langdahl","year":"2018","journal-title":"J. Bone Metab."},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.109207_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.biopha.2019.109207_bib0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000444634","article-title":"Rat osteosarcoma cells as a therapeutic target model for osteoregeneration via Sclerostin Knockdown","volume":"201","author":"Sedaghati","year":"2016","journal-title":"Cells Tissues Organs (Print)"},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/acs.molpharmaceut.7b01151","article-title":"Diosmetin induces apoptosis of acute myeloid leukemia cells","volume":"15","author":"Roma","year":"2018","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2019.109207_bib0170","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1158\/1535-7163.MCT-17-0292","article-title":"Estrogen receptor beta is a novel target in acute myeloid leukemia","volume":"16","author":"Rota","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2019.109207_bib0175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/endo.142.3.8003","article-title":"4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta","volume":"142","author":"Quaedackers","year":"2001","journal-title":"Endocrinology"},{"issue":"23","key":"10.1016\/j.biopha.2019.109207_bib0180","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1073\/pnas.90.23.11162","article-title":"Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene","volume":"90","author":"Lubahn","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.biopha.2019.109207_bib0185","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.biopha.2019.109207_bib0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/toxsci\/kfn141","article-title":"Influence of cellular ERalpha\/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells","volume":"105","author":"Sotoca","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2019.109207_bib0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0303-7207(96)03885-3","article-title":"Hormonal regulation of PKC-delta protein and mRNA levels in the rabbit corpus luteum","volume":"122","author":"Maizels","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109207_bib0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0303-7207(98)00229-9","article-title":"Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line","volume":"148","author":"Shanmugam","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109207_bib0205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/bjp.2008.305","article-title":"Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol","volume":"155","author":"Bitto","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109207_bib0210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcb.20308","article-title":"Genistein stimulates the osteoblastic differentiation via NO\/cGMP in bone marrow culture","volume":"94","author":"Pan","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2019.109207_bib0215","first-page":"515","article-title":"Anabolic effect of genistein in osteoblastic MC3T3-E1 cells","volume":"5","author":"Sugimoto","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2019.109207_bib0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2018.02.028","article-title":"Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: a critical assessment of the mechanism of action","volume":"826","author":"Bhattacharyya","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109207_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.10.019","article-title":"Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans","volume":"59","author":"Roforth","year":"2014","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.biopha.2019.109207_bib0230","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2019.109207_bib0235","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2019.109207_bib0240","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2019.109207_bib0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109207_bib0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1160\/TH07-07-0468","article-title":"Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis","volume":"99","author":"Adomaityte","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.biopha.2019.109207_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.biopha.2019.109207_bib0260","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219320104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219320104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:09:04Z","timestamp":1776427744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219320104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":52,"alternative-id":["S0753332219320104"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109207","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nutraceutical composition containing diosmin and hesperidin has osteogenic and anti-resorptive effects and expands the anabolic window of teriparatide","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109207"}}